Bayer in the news

Tobias Boldt, a long-time Bayer executive with extensive experience in consumer health and DTC, is joining Schwabe.

Bayer will invest $2.2 billion in a new pharmaceutical manufacturing campus in New Albany, Ohio, creating 600 jobs and enhancing its drug production capabilities in the U.S. market.

Bayer will invest $2.2bn in a new pharmaceutical manufacturing facility in Ohio, US, to produce treatments for cardiovascular, oncology, and renal care, creating hundreds of jobs and starting production in stages from 2031.

The DAX is set for a flat open, with global markets influenced by bond yields, economic data releases, and varying stock performances including Bayer's decline.

Bayer's stock declined, but the company is investing $2.2 billion in a new pharmaceutical production site in Ohio.

The DAX is set to open with a slight decline today, following a recovery on Friday driven by a weak US labor market report, while the oil market and economic data are in focus.

Bayer is building a $2.2 billion pharmaceutical manufacturing plant in New Albany, Ohio, which will create 600 jobs.

Bayer is investing $2.2 billion to construct a new pharmaceutical manufacturing campus in New Albany, Ohio, with operations expected to begin in phases from 2031.

Bayer is investing $2.2 billion to build a new pharmaceutical manufacturing campus in New Albany, Ohio, to produce medicines for oncology, cardiovascular, and renal care for both US and international markets.

Bayer's stock dropped over five percent due to new Glyphosate legal risks in a Missouri lawsuit, despite a recent mRNA patent victory, as the company anticipates Q3 2026 earnings amid ongoing legal challenges and a poor long-term stock rating.

The DAX closed slightly higher despite political uncertainties and high oil prices, with Rheinmetall and SAP gaining, while Bayer shares fell.

A new lawsuit against Bayer regarding Glyphosate and Roundup has started in the US, alleging insufficient product testing and inherent design flaws, which Bayer denies.

Bayer is investing $2.2 billion to build a new pharmaceutical plant in Ohio, adding 600 jobs and reinforcing its U.S. presence.

Bayer will invest $2.2 billion in a new pharmaceutical manufacturing plant in New Albany, Ohio, creating 600 permanent jobs.

Bayer is investing $2.2 billion in a new pharmaceutical plant in New Albany, creating 600 jobs.

Bayer will invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, creating 600 high-value jobs.

Bayer is investing $2.2 billion in a new high-tech manufacturing site in New Albany, Ohio, to bolster its U.S. presence and production of oncology, cardiovascular, and renal products, creating 600 new jobs.

Bayer's stock plunged due to glyphosate litigation, despite JPMorgan's continued 'Overweight' rating based on a positive operational outlook.

A 100 EUR investment in Bayer stock three years ago is now worth 101.19 EUR, showing a +1.19 percent return.

Bayer's stock fell sharply due to a new Roundup lawsuit in Missouri challenging the product's safety, potentially impacting the company's broader legal risk mitigation strategy.